Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Compound Danshen Dropping Pill for Coronary Heart Disease With Hypertension Patient Heart and Artery Structure and Function

NCT01825759 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT01825759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01825759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Compound Danshen Dropping Pill for Coronary Heart Disease With Hypertension Patient Heart and Artery Structure and Function
Lead sponsor
West China Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2013
Completion date
December 31, 2014
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, essential hypertension